BRAF-mutant transcriptional subtypes predict outcome of combined BRAF, MEK, and EGFR blockade with dabrafenib, trametinib, and panitumumab in patients with colorectal cancer
- Submitting institution
-
The University of Birmingham
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 92145082
- Type
- D - Journal article
- DOI
-
10.1158/1078-0432.CCR-19-3579
- Title of journal
- Clinical Cancer Research
- Article number
- -
- First page
- 2466
- Volume
- 26
- Issue
- 11
- ISSN
- 1078-0432
- Open access status
- Compliant
- Month of publication
- February
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
https://clincancerres.aacrjournals.org/highwire/filestream/179336/field_highwire_adjunct_files/0/231645_2_supp_6037020_q4gn1j.pdf
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
21
- Research group(s)
-
-
- Citation count
- 2
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author was the first author.
- Non-English
- No
- English abstract
- -
